Frontiers in Oncology | Cancer Immunity and Immunotherapy

Original Research

Published on 26 Jun 2024

Multiple immune-related adverse events secondary to checkpoint inhibitor therapy in patients with advanced cancer: association with treatment effectiveness

in Cancer Immunity and Immunotherapy

Cecilia Olsson Ladjevardi
Anthoula Koliadi
Viktoria Rydén
Ali Inan El-Naggar
Evangelos Digkas
Antonios Valachis
Gustav J. Ullenhag

Frontiers in Oncology

doi 10.3389/fonc.2024.1399171

1,486 views
3 citations

Case Report

Published on 21 Jun 2024

Case report: Drug-eluting bead transcatheter arterial chemoembolization in liver metastasis and retroperitoneal lymph node metastases of renal cell carcinoma: effective local therapy with the first report

in Cancer Immunity and Immunotherapy

Zhenkang Qiu
Junjie Ji
Shuo Zhang
Song Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1371414

681 views
1 citation

Case Report

Published on 21 Jun 2024

Thrombocytopenia and hyperprogression after radiotherapy and camrelizumab treatment in an esophageal cancer patient with increased JAK2 gene copies: a case report

in Cancer Immunity and Immunotherapy

Hang Wang
Yun Li
Min Qiu
Jianmin Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1283428

1,102 views
1 citation

Original Research

Published on 19 Jun 2024

Activation of non-classical Wnt signaling pathway effectively enhances HLA-A presentation in acute myeloid leukemia

in Cancer Immunity and Immunotherapy

YuHan Ma
JunShuai Yue
Ling Gao
JingXin Zhou
Wei Chen
Jing Su
JinRong Yao
QiaoMei Shi
XiaoDong Zhao
Na Hu

Frontiers in Oncology

doi 10.3389/fonc.2024.1336106

1,408 views

Case Report

Published on 19 Jun 2024

Apatinib manifests an unexpectedly favorable outcome in the management of axillary lymph node follicular dendritic cell sarcoma: a case report

in Cancer Immunity and Immunotherapy

Zhiying Feng
Zhonghai Du
Yan Liang
Juyue Zhou

Frontiers in Oncology

doi 10.3389/fonc.2024.1388982

1,188 views
1 citation

Original Research

Published on 18 Jun 2024

Comparative study of immune response to local tumor destruction modalities in a murine breast cancer model

in Cancer Immunity and Immunotherapy

Sadna Budhu
Kwanghee Kim
Wesley Yip
Stephen La Rosa
Sylvia Jebiwott
Liqun Cai
Aliya Holland
Jasmine Thomas
Dina Preise
Alex Somma

Frontiers in Oncology

doi 10.3389/fonc.2024.1405486

2,717 views

Case Report

Published on 14 Jun 2024

Long-term, 13-year survival after immune cell therapy combined with chemotherapy for extensive-stage small-cell lung cancer: a case report

in Cancer Immunity and Immunotherapy

Tong Liu
Heshuang Wang
Qinglong Kong
Haoyu Wang
Haodong Wei
Pengda Sun

Frontiers in Oncology

doi 10.3389/fonc.2024.1389725

1,390 views

Original Research

Published on 13 Jun 2024

Development of a diagnostic algorithm to ascertain malignant pleural effusion utilizing clinical indicators and serum metal concentrations

in Cancer Immunity and Immunotherapy

Jinling Ji
Ting Shi
Lei Yan
Kai Wang
Kun Jiang
Yuzhang Jiang
Shengnan Pan
Yabin Yu
Chang Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1431318

1,047 views

Review

Published on 11 Jun 2024

Challenges and innovations in CAR-T cell therapy: a comprehensive analysis

in Cancer Immunity and Immunotherapy

Jingming Luo
Xianwen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1399544

7,237 views
9 citations

Review

Published on 07 Jun 2024

Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review

in Cancer Immunity and Immunotherapy

Vahid Moradi
Elnaz Khodabandehloo
Mehdi Alidadi
Azadeh Omidkhoda
Naser Ahmadbeigi

Frontiers in Oncology

doi 10.3389/fonc.2024.1388475

8,064 views
7 citations

Original Research

Published on 05 Jun 2024

The effects of postoperative targeted immunotherapy on peripheral blood cytokines and immune cell profile in lung cancer patients

in Cancer Immunity and Immunotherapy

Chuang Zhang
Hongmei Mo
Min Li
Shuaiyan Wang
Xiaowen Dou
Xiuming Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1342624

1,383 views
1 citation

Original Research

Published on 31 May 2024

Mathematical model of MMC chemotherapy for non-invasive bladder cancer treatment

in Cancer Immunity and Immunotherapy

Marom Yosef
Svetlana Bunimovich-Mendrazitsky

Frontiers in Oncology

doi 10.3389/fonc.2024.1352065

1,641 views
1 citation

Original Research

Published on 29 May 2024

IRX5’s influence on macrophage polarization and outcome in papillary thyroid cancer

in Cancer Immunity and Immunotherapy

Lu Qin
Cheng Chen
Zhengwei Gui
Yun Jiang

Frontiers in Oncology

doi 10.3389/fonc.2024.1399484

1,251 views
1 citation

Review

Published on 29 May 2024

State-of-the-art cytometry in the search of novel biomarkers in digestive cancers

in Cancer Immunity and Immunotherapy

Carolina G. de Castro
Alejandro G. del Hierro
Juan H-Vázquez
Sara Cuesta-Sancho
David Bernardo

Frontiers in Oncology

doi 10.3389/fonc.2024.1407580

1,736 views
2 citations

Systematic Review

Published on 24 May 2024

Can adjuvant immune checkpoint inhibitors improve the long-term outcomes of hepatocellular carcinoma with high-risk recurrent factors after liver resection? A meta-analysis and systematic review

in Cancer Immunity and Immunotherapy

Lingbo Hu
Yenan Kong
Yingli Qiao
Aidong Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1374262

1,027 views

Case Report

Published on 24 May 2024

Case report: Regression after low-dose glucocorticoid therapy in a case of acute immune myocarditis induced by anti-PD-1 therapy for NSCLC

in Cancer Immunity and Immunotherapy

Liqianqi Chen
Suihao Zhang
Long Gong
Yucong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1404045

1,224 views
1 citation

Navigation group

Articles

Multiple immune-related adverse events secondary to checkpoint inhibitor therapy in patients with advanced cancer: association with treatment effectiveness

Case report: Drug-eluting bead transcatheter arterial chemoembolization in liver metastasis and retroperitoneal lymph node metastases of renal cell carcinoma: effective local therapy with the first report

Thrombocytopenia and hyperprogression after radiotherapy and camrelizumab treatment in an esophageal cancer patient with increased JAK2 gene copies: a case report

Activation of non-classical Wnt signaling pathway effectively enhances HLA-A presentation in acute myeloid leukemia

Apatinib manifests an unexpectedly favorable outcome in the management of axillary lymph node follicular dendritic cell sarcoma: a case report

Comparative study of immune response to local tumor destruction modalities in a murine breast cancer model

Long-term, 13-year survival after immune cell therapy combined with chemotherapy for extensive-stage small-cell lung cancer: a case report

Development of a diagnostic algorithm to ascertain malignant pleural effusion utilizing clinical indicators and serum metal concentrations

Challenges and innovations in CAR-T cell therapy: a comprehensive analysis

Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review

The effects of postoperative targeted immunotherapy on peripheral blood cytokines and immune cell profile in lung cancer patients

Mathematical model of MMC chemotherapy for non-invasive bladder cancer treatment

IRX5’s influence on macrophage polarization and outcome in papillary thyroid cancer

State-of-the-art cytometry in the search of novel biomarkers in digestive cancers

Can adjuvant immune checkpoint inhibitors improve the long-term outcomes of hepatocellular carcinoma with high-risk recurrent factors after liver resection? A meta-analysis and systematic review

Case report: Regression after low-dose glucocorticoid therapy in a case of acute immune myocarditis induced by anti-PD-1 therapy for NSCLC